Insights Into NTRK Gene Fusion-Positive Thyroid Cancer

Perspectives on drivers in treatment pathways for NTRK fusion-positive cancers

Southwest – March 29, 2022

Faculty Chair

Lori Wirth, MD

Massachusetts General Hospital Center for Head and Neck Cancers

More Information

  • Virtual series
  • Southern California, Nevada, Utah, Arizona, New Mexico, Colorado

Example Report

Start discovering the insights

View Report


  • A virtual, moderated roundtable discussion focusing on the treatment pathways for NTRK fusion-positive cancers
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights were obtained on the thyroid cancer disease landscape in the community setting, specifically testing protocols and treatment pathways for NTRK gene fusion-positive thyroid cancer


  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors will comprise 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.